As known, T2D develops when insulin secretion is impaired to a level that cannot compensate for systemic insulin resistance, and the presence of obesity can potentiate the progression of both insulin resistance and impaired insulin secretion. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.